Passage Bio, Inc.

Nasdaq PASG · Philadelphia, PA

Works in Metabolic & endocrine · Neurology · Psychiatry

Passage Bio, Inc. is a clinical trial sponsor based in Philadelphia, PA, listed as Nasdaq PASG. It has no active clinical trials as lead sponsor; its trials since 2021 were in Metabolic & endocrine, Neurology and Psychiatry. Since 2021 it has completed 0 trials and stopped 1 early.

Trial track record · since 2021

0Active trials0 planned participants
0Completed0 with results posted
1Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq PASG

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

Questions about Passage Bio, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-29.

Approve Suite is not affiliated with Passage Bio, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.